These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 16019133

  • 1. NCOR1 mRNA is an independent prognostic factor for breast cancer.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Hara Y, Kobayashi S, Iwase H.
    Cancer Lett; 2006 Jun 08; 237(1):123-9. PubMed ID: 16019133
    [Abstract] [Full Text] [Related]

  • 2. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
    Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bièche I.
    Clin Cancer Res; 2003 Apr 08; 9(4):1259-66. PubMed ID: 12684393
    [Abstract] [Full Text] [Related]

  • 3. Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Hara Y, Kobayashi S, Iwase H.
    Breast Cancer Res Treat; 2005 Nov 08; 94(1):11-6. PubMed ID: 16172792
    [Abstract] [Full Text] [Related]

  • 4. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H.
    Clin Cancer Res; 2006 Nov 01; 12(21):6410-4. PubMed ID: 17085653
    [Abstract] [Full Text] [Related]

  • 5. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Kawaguchi M, Miura Y, Iwase H.
    Clin Cancer Res; 2005 Jan 01; 11(1):193-8. PubMed ID: 15671546
    [Abstract] [Full Text] [Related]

  • 6. Nuclear corepressor 1 expression predicts response to first-line endocrine therapy for breast cancer patients on relapse.
    Zhang ZH, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Ibusuki M, Tomita S, Sugiura H, Kobayashi S, Fujii Y, Iwase H.
    Chin Med J (Engl); 2009 Aug 05; 122(15):1764-8. PubMed ID: 19781322
    [Abstract] [Full Text] [Related]

  • 7. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.
    APMIS; 2009 Sep 05; 117(9):644-50. PubMed ID: 19703124
    [Abstract] [Full Text] [Related]

  • 8. HDAC6 expression is correlated with better survival in breast cancer.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Omoto Y, Ando Y, Mita K, Hamaguchi M, Hayashi S, Iwase H.
    Clin Cancer Res; 2004 Oct 15; 10(20):6962-8. PubMed ID: 15501975
    [Abstract] [Full Text] [Related]

  • 9. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
    Płuciennik E, Kusińska R, Potemski P, Kubiak R, Kordek R, Bednarek AK.
    Eur J Surg Oncol; 2006 Mar 15; 32(2):153-7. PubMed ID: 16360296
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
    Woo SU, Bae JW, Kim CH, Lee JB, Koo BW.
    Ann Surg Oncol; 2008 Jan 15; 15(1):281-5. PubMed ID: 17763975
    [Abstract] [Full Text] [Related]

  • 12. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 13. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S, Tada M, Hida Y, Asano T, Kuramae T, Takemoto N, Hamada J, Miyamoto M, Hirano S, Kondo S, Moriuchi T.
    J Surg Res; 2008 May 01; 146(1):104-9. PubMed ID: 17663001
    [Abstract] [Full Text] [Related]

  • 14. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z, Yamashita H, Toyama T, Omoto Y, Sugiura H, Hara Y, Wu X, Kobayashi S, Iwase H.
    Breast Cancer Res; 2003 May 01; 5(6):R250-6. PubMed ID: 14580261
    [Abstract] [Full Text] [Related]

  • 15. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
    Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, Stratowa C, Kaserer K, Schreiber M.
    Clin Cancer Res; 2005 Dec 01; 11(23):8348-57. PubMed ID: 16322295
    [Abstract] [Full Text] [Related]

  • 16. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.
    Breast Cancer Res Treat; 2007 Mar 01; 101(3):279-84. PubMed ID: 16835704
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
    Fujii T, Kawahara A, Basaki Y, Hattori S, Nakashima K, Nakano K, Shirouzu K, Kohno K, Yanagawa T, Yamana H, Nishio K, Ono M, Kuwano M, Kage M.
    Cancer Res; 2008 Mar 01; 68(5):1504-12. PubMed ID: 18316615
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.